Reference
Anchisi S, et al. Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient. Cancer Biology and Therapy 24: 2193116, No. 1, Jan 2023. Available from: URL: http://doi.org/10.1080/15384047.2023.2193116
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1955, 40 (2023). https://doi.org/10.1007/s40278-023-38287-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-38287-3